{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:38:18Z","timestamp":1787981898190,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jiac.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T11:54:00Z","timestamp":1512647640000},"page":"315-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens"],"prefix":"10.1016","volume":"24","author":[{"given":"Eun Hye","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jae","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Mi","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Youn","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jung","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.10.022_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.10.022_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1164\/rccm.201501-0067OC","article-title":"Comparison of clinical features, virulence, and relapse among Mycobacterium avium complex species","volume":"191","author":"Boyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.10.022_bib3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.12-0494","article-title":"Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease","volume":"142","author":"Koh","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2017.10.022_bib4","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/JCM.02127-14","article-title":"Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare","volume":"52","author":"Renvoise","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.10.022_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2015.01.012","article-title":"Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China","volume":"45","author":"Zhang","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.10.022_bib6","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1099\/jmm.0.000376","article-title":"Comparative evaluation of the AdvanSure Mycobacteria GenoBlot assay and the GenoType Mycobacterium CM\/AS assay for the identification of non-tuberculous mycobacteria","volume":"65","author":"Yang","year":"2016","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jiac.2017.10.022_bib7","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard","author":"Clinical Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.jiac.2017.10.022_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.10.022_bib9","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","article-title":"In\u00a0vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates","volume":"51","author":"Brown-Elliott","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.10.022_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijid.2016.12.027","article-title":"Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints","volume":"55","author":"Schon","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2017.10.022_bib11","first-page":"324","article-title":"The antimicrobial susceptibility of non-tuberculous mycobacteria","volume":"72","author":"Cowman","year":"2016","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2017.10.022_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijantimicag.2009.09.023","article-title":"In\u00a0vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands","volume":"35","author":"van Ingen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.10.022_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijantimicag.2016.10.024","article-title":"Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria","volume":"49","author":"Li","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.10.022_bib14","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.10.022_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diagmicrobio.2017.02.017","article-title":"Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens","volume":"88","author":"Kim","year":"2017","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17302787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17302787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:28Z","timestamp":1761159448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17302787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1341321X17302787"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.10.022","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}